Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNEUROPHARMACOLOGY

Antinociceptive Activity of [β-Methyl-2′,6′-dimethyltyrosine1]-Substituted Cyclic [d-Pen2,d-Pen5]Enkephalin and [d-Ala2,Asp4]Deltorphin Analogs

Edward J. Bilsky, Xinhua Qian, Victor J. Hruby and Frank Porreca
Journal of Pharmacology and Experimental Therapeutics April 2000, 293 (1) 151-158;
Edward J. Bilsky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinhua Qian
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor J. Hruby
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Porreca
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Research in our laboratories involves the development of selective opioid agonists and antagonists as: 1) pharmacological tools to elucidate the mechanisms of opioid antinociception, and 2) potential analgesics that possess therapeutic advantages over currently available drugs. We hypothesized that the selectivity of peptide agonists toward the opioid receptor types and subtypes is topographically dependent. The current results assess the antinociceptive activity and opioid receptor selectivity of a series of β-methyl-2′,6′-dimethyltyrosine (TMT)-substituted cyclic [d-Pen2,d-Pen5]enkephalin (DPDPE) and [d-Ala2,Asp4]deltorphin (DELT I) analogs. Compounds were injected via the intracerebroventricular route into male ICR mice, and antinociception was assessed using the 55°C warm water tail-flick test. Antinociceptive A50 values ranged from 0.35 to 17 nmol for the DELT I analogs and from 7.05 to >100 nmol for the DPDPE analogs. To test for receptor selectivity, mice were treated with selective μ- and δ-opioid antagonists. In general, μ [β-funaltrexamine (β-FNA)]- and δ1([d-Ala2,Leu5,Cys6] enkephalin)-antagonists blocked the antinociceptive actions of [TMT1]DPDPE analogs, whereas the antinociceptive actions of [TMT1]DELT I analogs were more sensitive to antagonism by the δ2-selective antagonist [Cys4]deltorphin and the μ-antagonist β-FNA. The antinociceptive actions of the [(2R,3S)-TMT1]DELT I analog was suppressed by both [d-Ala2,Leu5, Cys6]enkephalin and β-FNA. These results are in contrast to those found with the parent molecules DPDPE (primarily a δ1 agonist) and DELT I (a mixed δ1/δ2 agonist). These results demonstrate that topographical modification in position 1 of the DPDPE and DELT I peptides affects antinociceptive potency and opioid receptor selectivity.

Footnotes

  • Send reprint requests to: Edward Bilsky, Ph.D., Department of Biological Sciences, University of Northern Colorado, Greeley, CO 80639. E-mail: ejbilsk{at}bentley.unco.edu

  • ↵1 This work was supported by National Institute on Drug Abuse Grant DA06284. The views expressed are those of the authors and not necessarily those of the U.S. Public Health Service.

  • Abbreviations:
    DELT I
    [d-Ala2,Asp4]deltorphin, H2-Tyr-d-Ala-Phe-Asp-Val-Val-Gly-NH2
    β-FNA
    β-funaltrexamine
    DALCE
    [d-Ala2,Leu5, Cys6]enkephalin
    DPDPE
    cyclic [d-Pen2,d-Pen5]enkephalin, where Pen is penicillamine
    i.c.v.
    intracerebroventricular
    MVD
    mouse vas deferens
    TMT
    β-methyl-2′,6′-dimethyltyrosine
    • Received October 19, 1999.
    • Accepted December 30, 1999.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 293 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 293, Issue 1
1 Apr 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antinociceptive Activity of [β-Methyl-2′,6′-dimethyltyrosine1]-Substituted Cyclic [d-Pen2,d-Pen5]Enkephalin and [d-Ala2,Asp4]Deltorphin Analogs
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNEUROPHARMACOLOGY

Antinociceptive Activity of [β-Methyl-2′,6′-dimethyltyrosine1]-Substituted Cyclic [d-Pen2,d-Pen5]Enkephalin and [d-Ala2,Asp4]Deltorphin Analogs

Edward J. Bilsky, Xinhua Qian, Victor J. Hruby and Frank Porreca
Journal of Pharmacology and Experimental Therapeutics April 1, 2000, 293 (1) 151-158;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleNEUROPHARMACOLOGY

Antinociceptive Activity of [β-Methyl-2′,6′-dimethyltyrosine1]-Substituted Cyclic [d-Pen2,d-Pen5]Enkephalin and [d-Ala2,Asp4]Deltorphin Analogs

Edward J. Bilsky, Xinhua Qian, Victor J. Hruby and Frank Porreca
Journal of Pharmacology and Experimental Therapeutics April 1, 2000, 293 (1) 151-158;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • P-Glycoprotein Apical Efflux Ratio for Compound Optimization
  • Pharmacology of Carbamate Insecticides at Melatonin Receptors
  • Metalloporphyrins modify disease outcomes in parkinsonism
Show more Neuropharmacology

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics